Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA is a clinical research site located in Los Angeles, California, United States 90095.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA has participated in 1 clinical trials.
Therapeutic areas: Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma.
Sponsors: University of California, San Diego.
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA has 1 clinical trials on record. Their work covers Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma.
Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.